Jaguar Health Announces Third Quarter 2024 Financial Results
Jaguar Health Reports Strong Q3 2024 Results Financial Success and Promising Drug Trials Jaguar Health, Inc. has announced impressive financial results for the third quarter of 2024, with a combined net revenue of approximately $3.1 million for prescription and non-prescription products. This represents a 14% increase from the previous quarter and an 11% increase from…